Health News Roundup: AstraZeneca’s Enhertu wins keenly-anticipated US breast cancer nod; Russia’s official toll of COVID-related deaths exceeds 820,000 and more

Following is a summary of current health news briefs. AstraZeneca’s Enhertu wins keenly-anticipated US breast cancer nod AstraZeneca and Daiichi

Read more

Health News Roundup: Russia’s official toll of COVID-related deaths exceeds 820,000; US FDA declines to approve expanded use of Acadia’s antipsychotic drug and more

Following is a summary of current health news briefs. AstraZeneca’s Enhertu wins keenly-anticipated US breast cancer nod AstraZeneca and Daiichi

Read more

FDA Updates for Week of Aug. 1, 2022

The FDA has made several approvals this week, including Enhertu for HER2-low breast cancer, a steroid-free cream for plaque psoriasis

Read more

Trastuzumab Deruxtecan Continues to Show Safety in Metastatic Breast Cancer

A safety follow-up of the phase 3 DESTINY-Breast03 study (NCT03529110) revealed no new safety signals to be found with fam-trastuzumab

Read more